Evaluation of the NHS National Cancer Vanguard

Evaluation of the NHS National Cancer Vanguard: Year 1 report
Cancer Vanguard 8 October 2018

• The Cancer Vanguard was established to pilot and roll out new models of care that would provide innovative high quality cancer care across the whole patient pathway. The Vanguard as a formal collaboration ended at the end of March 2018.
• The evaluation identified the following key partner-level conditions for success:
• Strong local leadership for cancer transformation at programme level
• High-performing teams of project and change managers
• Openness to collaborate across organisational boundaries
• Collaborative working with patients and patient representatives
• A climate of research collaboration
• A strong network of collaboration with cancer charities
• As well as the full report and Executive Summary, an illustration explaining the Cancer Vanguard and the findings of the evaluation are available.

Scaling up single specialty networked care - lessons from Moorfields

Scaling up single specialty networked care: A strategic overview
Networked Care, March 2018 

• In April 2017 the Moorfields vanguard team published a e-toolkit sharing findings from the research into best practice for single specialty networked care. (www.networkedcaretoolkit.org.uk) 
• This report shares findings from semi-structured interviews with more than 35 strategic decision makers across the NHS (providers, commissioners and regulators), and other sectors, as well as a desktop literature review, on the benefits and challenges of scaling up networked care numerically and geographically. 

Moorfields also published two other reports:

Spreading best practice UK Ophthalmology Alliance
Networked Care, March 2018

• Experience and advice from replicating the National Orthopaedic Alliance (NOA) membership model across ophthalmology nationally.

Staff and patients Improving networked care, 
Networked Care, March 2018

• A description of work with the independent charity, the POCF, to understand the best methods and tools to embed staff and patient co-design of services across the Moorfields network.

Spreading best practice UK Ophthalmology Alliance

Spreading best practice UK Ophthalmology Alliance
Networked Care March 2018

• The aim of the National Orthopaedic Alliance (NOA) vanguard programme was to create a UK-wide alliance of orthopaedic providers to deliver outstanding and consistent care in more areas. The NOA vanguard has developed a consistent benchmarking framework, describing not only ‘what good looks like’ in orthopaedic care but also the components of a quality improvement journey. 
• This publication shares experience and advice from replicating the membership model across ophthalmology nationally.

New Joint Working Projects with national Cancer Vanguard sites

New Joint Working Projects with national Cancer Vanguard sites
Novartis 20 March 2018

• Novartis has announced the launch of two new Joint Working Projects with national Cancer Vanguard sites, which aim to identify ways to improve cancer patient care pathways and access to services.
• The Joint Working Project with UCLH Cancer Collaborative (north and east London) will adopt the use of Multi-Disciplinary Team (MDT) level balanced scorecards to capture service outcomes data for breast, lung, lymphoma, melanoma, and prostate cancer patient pathways.
• The Joint Working Project with The Christie NHS Foundation Trust will work to address care pathway inconsistencies in breast cancer.

Communities of Practice event for Cancer Alliances

Communities of Practice event for Cancer Alliances
28 February 2018

• A Communities of Practice event focusing on developing best practice timed pathways for colorectal, lung, prostate and upper GI cancers.
• The Presentations from the event including
• Context Setting, Jenny Scott, Programme Director, Greater Manchester Cancer Vanguard Innovation
• The National Cancer Programme, Professor Chris Harrison, National Clinical Director for Cancer
• Issues and Opportunities in developing timed pathways, Nicola Hunt, Managing Director, RM Partners
• Vanguard work on timed pathways, Professor Kathy Pritchard-Jones, Chief Medical Officer, UCLH Cancer Collaborative
• Best Practice Timed Prostate Pathway, Satish Maddineni, Consultant Urological Surgeon, Salford Royal and The Christie NHS Foundation Trust 
• Using MRI in Prostate Pathway, Caroline Moore, Reader in Urology, UCL
• The RAPID Prostate Pathway, Professor Hashim Ahmed, Chair of Urology, Imperial College London

The Cancer Vanguard: NHS and pharma partnership improves patient experience

The Cancer Vanguard: NHS and pharma partnership improves patient experience
PharmaPhorum 7 February 2018

• Discussion of the learning from the Cancer Vanguard-Merck-IQVIA-UMOTIF joint working initiative from a recent IQVIA/pharmaphorum roundtable discussion, “Improving outcomes through industry partnership – the Cancer Vanguard learnings”.
• The Christie collaboration looked at how to use NHS resources more efficiently, improving quality, reducing unwarranted variation in care and establishing a better understanding of the experience of cancer patients during treatment. By collecting relevant data, it has helped to shape an evidence-based and patient-centric approach to service redesign and resource optimisation. One novel aspect of the study involved asking patients to record their symptoms – such as mobility, and energy levels – using uMotif’s smartphone-based app.

Networked Care online toolkit

Networked Care http://www.networkedcaretoolkit.org.uk/

• An online toolkit to share learning around developing sustainable single specialty services created by Mooorfields Vanguard Programme team. Includes practical advice, frameworks, guidance, and case studies resources.
• (Registration required)